Amare Gashaw, Cherie Niguss, Mekonen Asnakew Molla
Department of Reproductive Health and Family Health, School of Public Health, College of Medicine and Health Sciences, Wollo University, Dessie, Amhara, Ethiopia.
Department of Health Systems Management, School of Public Health, College of Medicine and Health Sciences, Wollo University, Dessie, Amhara, Ethiopia.
HIV AIDS (Auckl). 2021 Jan 26;13:107-114. doi: 10.2147/HIV.S289045. eCollection 2021.
Dual contraceptive method use is defined as the use of any modern contraceptive method with a condom for the reduction of mother-to-child transmission of HIV and sexually transmitted infections between sexual partners. The goal of this study was to assess the proportion and factors associated with dual contraceptive use among reproductive age women on antiretroviral therapy in Borena district, Northeast Ethiopia.
To assess the proportion of dual contraceptive use and associated factors among the reproductive age women on antiretroviral therapy in Borena district, Northeast Ethiopia.
An institutional-based cross-sectional study was conducted among HIV positive reproductive age group women on antiretroviral therapy in Borena district from February 1 to March 1, 2020. A systematic random sampling technique was used to include 417 study participants. A structured interviewer-administered questionnaire was used to collect the data. A binary logistic regression model was used to identify the factors associated with dual contraceptive use. Odds ratio with 95% confidence interval (CI) and -value were calculated to assess the strength of association.
The results showed that 19.4% of the HIV positive reproductive age group on antiretroviral therapy were using dual contraceptive method. Urban area (AOR=3.66, 95% CI=1.66-8.09), educated to secondary education and above (AOR=3.54, 95% CI=1.29-9.76), those who have no desire to have a child (AOR=4.41, 95% CI=2.66-7.59), those with partners whose HIV status was negative (AOR=4.96, 95% CI=2.66-12.02) and those with partners whose HIV status was positive (AOR=2.45, 95% CI=1.25-4.81) were more likely to use the dual contraception method.
This study showed that the proportion of dual contraceptive use was found to be low in accordance with the WHO recommendation. Therefore increased awareness on the advantages of dual contraception and knowing partner's HIV status is important.
双重避孕方法的使用被定义为同时使用任何现代避孕方法和避孕套，以减少母婴传播艾滋病毒以及性伴侣之间的性传播感染。本研究的目的是评估埃塞俄比亚东北部博雷纳地区接受抗逆转录病毒治疗的育龄妇女中双重避孕方法使用的比例及相关因素。
评估埃塞俄比亚东北部博雷纳地区接受抗逆转录病毒治疗的育龄妇女中双重避孕方法使用的比例及相关因素。
2020年2月1日至3月1日，在博雷纳地区对接受抗逆转录病毒治疗的HIV阳性育龄妇女开展了一项基于机构的横断面研究。采用系统随机抽样技术纳入417名研究参与者。使用结构化的访谈式问卷收集数据。采用二元逻辑回归模型确定与双重避孕方法使用相关的因素。计算比值比及95%置信区间（CI）和P值以评估关联强度。
结果显示，接受抗逆转录病毒治疗的HIV阳性育龄妇女中，19.4%使用双重避孕方法。城区（比值比=3.66，95%CI=1.66 - 8.09）、受过中等及以上教育（比值比=3.54，95%CI=1.29 - 9.76）、无生育意愿者（比值比=4.41，95%CI=2.66 - 7.59）、伴侣HIV状态为阴性者（比值比=4.96，95%CI=2.66 - 12.02）以及伴侣HIV状态为阳性者（比值比=2.45，95%CI=1.25 - 4.81）更有可能使用双重避孕方法。
本研究表明，根据世界卫生组织的建议，双重避孕方法的使用比例较低。因此，提高对双重避孕优势的认识以及了解伴侣的HIV状态很重要。
